IFC & Insurance Marketing’s Pfizer PFE Stock Holding History

IFC & Insurance Marketing’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,377	Closed	-$34K	–	502
2025 Q4	$34K	Buy	+1,377	New	+$34.7K	0.03%	217

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

IFC & Insurance Marketing's PFE Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of Pfizer (PFE) in Q1 2026, closing a stake of 1,377 shares — an estimated $34K sold.

IFC & Insurance Marketing first reported a position in PFE in Q4 2025 and held it in 1 quarter. The position peaked at $34K in Q4 2025. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

IFC & Insurance Marketing reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
IFC & Insurance Marketing sold 1,377 Pfizer shares in Q1 2026, an estimated $34K.
IFC & Insurance Marketing first reported a position in Pfizer in Q4 2025 and held it in 1 quarter.
IFC & Insurance Marketing's Pfizer position peaked at $34K in Q4 2025.
2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.